Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan B Angel

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
Current HIV Research|September 6, 2023
Donating One's Body to HIV Cure Research Through Canadian Medical Assistance in Dying: A Case StudyDavid Lessard, Bertrand Lebouché, André Morneau, et al.
AIDS Patient Care and Stds|January 10, 2023
Factors Associated with Health Care Providers' Preference for Forgoing an Oral Lead-In Phase When Initiating Long-Acting Injectable Cabotegravir and Rilpivirine in the SOLAR Clinical TrialTahilin Sanchez Karver, Miguel Pascual-Bernaldez, Alessandro Berni, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 29, 2025
Thigh Injections of Cabotegravir + Rilpivirine in Virally Suppressed Adults With Human Immunodeficiency Virus Type 1: A Substudy of the Phase 3b ATLAS-2M StudySusan L Ford, Franco Felizarta, Kelong Han, et al.
Ebiomedicine|March 4, 2021
LILAC pilot study: Effects of metformin on mTOR activation and HIV reservoir persistence during antiretroviral therapyDelphine Planas, Amélie Pagliuzza, Rosalie Ponte, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 10, 2011
Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structuresMansoureh Hakimi, Thirumahal Selvanantham, Erika Swinton, et al.
Plos One|December 10, 2009
Fertility desires and intentions of HIV-positive women of reproductive age in Ontario, Canada: a cross-sectional studyMona R Loutfy, Trevor A Hart, Saira S Mohammed, et al.
Viruses|February 28, 2023
SARS-CoV-2 Vaccine-Induced T-Cell Response after Three Doses in People Living with HIV on Antiretroviral Therapy Compared to Seronegative Controls (CTN 328 COVAXHIV Study)Yulia Alexandrova, Alexis Yero, Ralph-Sydney Mboumba Bouassa, et al.
BMJ Open|December 17, 2021
CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort studyCecilia T Costiniuk, Joel Singer, Marc-André Langlois, et al.
Antiviral Therapy|November 21, 2007
External quality assessment of HLA-B*5701 reporting: an international multicentre surveyEmma Hammond, Coral-Ann Almeida, Cyril Mamotte, et al.
Cell Reports|September 7, 2023
Near full-length HIV sequencing in multiple tissues collected postmortem reveals shared clonal expansions across distinct reservoirs during ARTCaroline Dufour, Maria Julia Ruiz, Amélie Pagliuzza, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
Current HIV Research|September 6, 2023
Donating One's Body to HIV Cure Research Through Canadian Medical Assistance in Dying: A Case StudyDavid Lessard, Bertrand Lebouché, André Morneau, et al.
AIDS Patient Care and Stds|January 10, 2023
Factors Associated with Health Care Providers' Preference for Forgoing an Oral Lead-In Phase When Initiating Long-Acting Injectable Cabotegravir and Rilpivirine in the SOLAR Clinical TrialTahilin Sanchez Karver, Miguel Pascual-Bernaldez, Alessandro Berni, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 29, 2025
Thigh Injections of Cabotegravir + Rilpivirine in Virally Suppressed Adults With Human Immunodeficiency Virus Type 1: A Substudy of the Phase 3b ATLAS-2M StudySusan L Ford, Franco Felizarta, Kelong Han, et al.
Ebiomedicine|March 4, 2021
LILAC pilot study: Effects of metformin on mTOR activation and HIV reservoir persistence during antiretroviral therapyDelphine Planas, Amélie Pagliuzza, Rosalie Ponte, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 10, 2011
Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structuresMansoureh Hakimi, Thirumahal Selvanantham, Erika Swinton, et al.
Plos One|December 10, 2009
Fertility desires and intentions of HIV-positive women of reproductive age in Ontario, Canada: a cross-sectional studyMona R Loutfy, Trevor A Hart, Saira S Mohammed, et al.
Viruses|February 28, 2023
SARS-CoV-2 Vaccine-Induced T-Cell Response after Three Doses in People Living with HIV on Antiretroviral Therapy Compared to Seronegative Controls (CTN 328 COVAXHIV Study)Yulia Alexandrova, Alexis Yero, Ralph-Sydney Mboumba Bouassa, et al.
BMJ Open|December 17, 2021
CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort studyCecilia T Costiniuk, Joel Singer, Marc-André Langlois, et al.
Antiviral Therapy|November 21, 2007
External quality assessment of HLA-B*5701 reporting: an international multicentre surveyEmma Hammond, Coral-Ann Almeida, Cyril Mamotte, et al.
Cell Reports|September 7, 2023
Near full-length HIV sequencing in multiple tissues collected postmortem reveals shared clonal expansions across distinct reservoirs during ARTCaroline Dufour, Maria Julia Ruiz, Amélie Pagliuzza, et al.
Pageof 14